Cite
Cimbaljevic S, Suvakov S, Matic M, et al. Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival. J Med Biochem. 2016;35(3):302-311doi: 10.1515/jomb-2016-0009.
Cimbaljevic, S., Suvakov, S., Matic, M., Pljesa-Ercegovac, M., Pekmezovic, T., Radic, T., Coric, V., Damjanovic, T., Dimkovic, N., Markovic, R., Savic-Radojevic, A., & Simic, T. (2016). Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival. Journal of medical biochemistry, 35(3), 302-311. https://doi.org/10.1515/jomb-2016-0009
Cimbaljevic, Slavica, et al. "Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival." Journal of medical biochemistry vol. 35,3 (2016): 302-311. doi: https://doi.org/10.1515/jomb-2016-0009
Cimbaljevic S, Suvakov S, Matic M, Pljesa-Ercegovac M, Pekmezovic T, Radic T, Coric V, Damjanovic T, Dimkovic N, Markovic R, Savic-Radojevic A, Simic T. Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival. J Med Biochem. 2016 Sep;35(3):302-311. doi: 10.1515/jomb-2016-0009. Epub 2016 Jul 06. PMID: 28356881; PMCID: PMC5346808.
Copy
Download .nbib